Foghorn Therapeutics
Foghorn Therapeutics conducts research on and manufactures pharmaceuticals used for the treatment of genetic diseases. This company is headquartered in Cambridge, Massachusetts and was established in 2016.
Last updated on
About Foghorn Therapeutics
Founded
2016Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$120MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541712Location
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (60)
